SCHOLAR ROCK HOLDING CORPORATION Other Nonoperating Income (Expense)
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Other Nonoperating Income (Expense) of -$570.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-06
- SCHOLAR ROCK HOLDING CORPORATION other nonoperating income (expense) for the quarter ending 2026-06-30 was -$570.00K.
- SCHOLAR ROCK HOLDING CORPORATION other nonoperating income (expense) for the quarter ending 2026-03-31 was -$790.00K.
- SCHOLAR ROCK HOLDING CORPORATION other nonoperating income (expense) for the quarter ending 2025-12-31 was -$61.00K.
- SCHOLAR ROCK HOLDING CORPORATION other nonoperating income (expense) for the quarter ending 2025-09-30 was -$69.00K.
- SCHOLAR ROCK HOLDING CORPORATION other nonoperating income (expense) for fiscal 2025 was -$301.00K.
- SCHOLAR ROCK HOLDING CORPORATION other nonoperating income (expense) for fiscal 2024 was -$85.00K.
- SCHOLAR ROCK HOLDING CORPORATION other nonoperating income (expense) for fiscal 2018 was -$56.00K.
- SCHOLAR ROCK HOLDING CORPORATION other nonoperating income (expense) for fiscal 2017 was -$10.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$570.00K 10-Q · filed 2026-08-06 | -$1.36M 10-Q · filed 2026-08-06 | -$1.42M derived: sum of 3 quarters · filed 2026-08-06 | -$1.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$790.00K 10-Q · filed 2026-05-07 | -$851.00K derived: sum of 2 quarters · filed 2026-05-07 | -$920.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$130.00K derived: sum of 2 quarters · filed 2026-03-03 | -$257.00K derived: sum of 3 quarters · filed 2026-08-06 | -$301.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | -$69.00K 10-Q · filed 2025-11-14 | -$196.00K derived: sum of 2 quarters · filed 2026-08-06 | -$240.00K 10-Q · filed 2025-11-14 | -$252.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$127.00K 10-Q · filed 2026-08-06 | -$171.00K 10-Q · filed 2026-08-06 | -$183.00K derived: sum of 3 quarters · filed 2026-08-06 | -$221.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$44.00K 10-Q · filed 2026-05-07 | -$56.00K derived: sum of 2 quarters · filed 2026-05-07 | -$94.00K derived: sum of 3 quarters · filed 2026-05-07 | -$108.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$50.00K derived: sum of 2 quarters · filed 2026-03-03 | -$64.00K derived: sum of 3 quarters · filed 2026-03-03 | -$85.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | -$38.00K 10-Q · filed 2025-11-14 | -$52.00K derived: sum of 2 quarters · filed 2025-11-14 | -$73.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$14.00K 10-Q · filed 2025-08-06 | -$36.00K 10-Q · filed 2025-08-06 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $0.00 derived: sum of 2 quarters · filed 2019-03-19 | -$36.00K derived: sum of 3 quarters · filed 2019-03-19 | -$56.00K 10-K · filed 2019-03-19 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$36.00K derived: sum of 2 quarters · filed 2018-11-08 | -$56.00K 10-Q · filed 2018-11-08 | -$67.00K derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-06-30 | -$36.00K 10-Q · filed 2018-08-08 | -$56.00K 10-Q · filed 2018-08-08 | -$67.00K derived: sum of 3 quarters · filed 2019-05-15 | -$63.00K derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-03-31 | -$20.00K 10-Q · filed 2019-05-15 | -$31.00K derived: sum of 2 quarters · filed 2019-05-15 | -$27.00K derived: sum of 3 quarters · filed 2019-05-15 | -$29.00K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | -$7.00K derived: sum of 2 quarters · filed 2019-03-19 | -$9.00K derived: sum of 3 quarters · filed 2019-03-19 | -$10.00K 10-K · filed 2019-03-19 |
| 2017-09-30 | $4.00K 10-Q · filed 2018-11-08 | $2.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | -$2.00K 10-Q · filed 2018-08-08 | -$3.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |